Roche Media 23 abr 2026 Roche Q1 earnings suffer blood bath, but currency headwinds aren’t the only culprit - Fierce Pharma
Roche Media 23 abr 2026 From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree - Fierce Biotech
Roche Media 21 abr 2026 With successful trials, Roche takes its MS drug to regulators, but safety questions loom - statnews.com
Roche Media 21 abr 2026 Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce Biotech
Roche Media 17 abr 2026 Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout - Medical Device Network
Roche Media 17 abr 2026 Roche affiliate to acquire Triangle diagnostics firm for up to $595M - The Business Journals
Roche Media 16 abr 2026 Roche to launch another Elevidys trial, with eyes on European approval - statnews.com
Roche Media 15 abr 2026 Could Roche’s Top-Selling Drug Be Harming Women with Primary Progressive Multiple Sclerosis? - Bioengineer.org
Roche Media 9 abr 2026 Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders - Fierce Biotech
Roche Media 6 abr 2026 2MM: AI Roundup – Roche and NVIDIA’s AI drug discovery factory and surgical robotics foundation model, Amazon’s nationwide health AI expansion, and Brown’s AI therapy ethics warning [March 2026] - 2 Minute Medicine
Roche Media 29 mar 2026 NHIA, Roche deepen reform push to accelerate universal health coverage - Businessday NG
Roche Media 26 mar 2026 Personalising diabetes care: a holistic approach to cardiometabolic health - Roche
Roche Media 23 mar 2026 Ministry of Health and Population and Roche Diagnostics sign MoU to advance digital pathology in Egypt - Intelligent CIO